Gilead Sciences
GILD
#126
Rank
NZ$276.57 B
Marketcap
NZ$222.76
Share price
-0.02%
Change (1 day)
20.17%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.73

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.81. In 2024 the company made an earnings per share (EPS) of NZ$0.66 a decrease over its 2023 EPS that were of NZ$7.85.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.731689.72%
2024NZ$0.66-91.65%
2023NZ$7.8523.98%
2022NZ$6.33-25.86%
2021NZ$8.544850%
2020NZ$0.17-97.64%
2019NZ$7.310.9%
2018NZ$7.2518.71%
2017NZ$6.11-64.88%
2016NZ$17.38-18.45%
2015NZ$21.3255.28%
2014NZ$13.73296.02%
2013NZ$3.4717.89%
2012NZ$2.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.07 27.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.26-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.55-69.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.68 312.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.97 111.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$16.13 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.54-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$29.34 148.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.14-48.07%๐Ÿ‡บ๐Ÿ‡ธ USA